A novel method to assess drug efficacy in the real world finds benefit of olaparib in Veterans with prostate cancer whose tumors harbor BRCA2 mutationsHarshraj Leuva,Tito Fojo, Carol Luhrssemanticscholar（2020）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
